Skip to main content
Clinical Trials/IRCT20170417033491N2
IRCT20170417033491N2
Completed
Phase 3

Comparison of the effect of Bupivacaine 0.5% , Lidocaine 5% , Pethidine , Lidocaine 5% & intratecal on the incidence of decrease blood pressure , nausea and vometing for elective caesarean section

Gerash University of Medical Sciences0 sites75 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Gerash University of Medical Sciences
Enrollment
75
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Gerash University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 45 \- 18 years
  • Term pregnancy (42\-37 weeks)
  • Willingness to participate in the study
  • NPO (Nil Per Os)
  • Elective caesarean section

Exclusion Criteria

  • Operation duration more than 80 minutes
  • Using ritodrine or other beta tocolytic
  • Fetal abnormalities or pregnancy complications
  • Failure in performing spinal
  • Low level of blocks (block level lower than T8\)
  • Stomachache; metabolic diseases; hypertension; nausea and vomiting before surgery
  • Any underlying diseases
  • Complications during surgery
  • Arterial or venous disease in lower extremities
  • Defects in the immune system and gestational diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials